The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback